These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1314177)

  • 1. Synergistic combination of azithromycin and sulfadiazine for treatment of toxoplasmosis in mice.
    Araujo FG; Lin T; Remington JS
    Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):71-3. PubMed ID: 1314177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic activity of azithromycin and pyrimethamine or sulfadiazine in acute experimental toxoplasmosis.
    Derouin F; Almadany R; Chau F; Rouveix B; Pocidalo JJ
    Antimicrob Agents Chemother; 1992 May; 36(5):997-1001. PubMed ID: 1324642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activity of atovaquone (566C80) in murine toxoplasmosis is markedly augmented when used in combination with pyrimethamine or sulfadiazine.
    Araujo FG; Lin T; Remington JS
    J Infect Dis; 1993 Feb; 167(2):494-7. PubMed ID: 8421189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New pathogens and mode of action of azithromycin: Toxoplasma gondii].
    Derouin F
    Pathol Biol (Paris); 1995 Jun; 43(6):561-4. PubMed ID: 8539083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic activity of azithromycin and gamma interferon in murine toxoplasmosis.
    Araujo FG; Remington JS
    Antimicrob Agents Chemother; 1991 Aug; 35(8):1672-3. PubMed ID: 1656872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxoplasma gondii: the effect of fluconazole combined with sulfadiazine and pyrimethamine against acute toxoplasmosis in murine model.
    Martins-Duarte ÉS; de Souza W; Vommaro RC
    Exp Parasitol; 2013 Mar; 133(3):294-9. PubMed ID: 23270807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clarithromycin-minocycline is synergistic in a murine model of toxoplasmosis.
    Araujo FG; Prokocimer P; Remington JS
    J Infect Dis; 1992 Apr; 165(4):788. PubMed ID: 1532409
    [No Abstract]   [Full Text] [Related]  

  • 8. Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii.
    Araujo FG; Guptill DR; Remington JS
    Antimicrob Agents Chemother; 1988 May; 32(5):755-7. PubMed ID: 2840017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azithromycin prophylaxis and treatment of murine toxoplasmosis.
    Tabbara KF; Hammouda E; Tawfik A; Al-Omar OM; Abu El-Asrar AM
    Saudi Med J; 2005 Mar; 26(3):393-7. PubMed ID: 15806206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the efficacy of atovaquone alone or in combination with azithromycin against acute murine toxoplasmosis.
    Moshkani SK; Dalimi A
    Vet Res Commun; 2000 Apr; 24(3):169-77. PubMed ID: 10836275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo activity of the macrolide antibiotics azithromycin, roxithromycin and spiramycin against Toxoplasma gondii.
    Araujo FG; Shepard RM; Remington JS
    Eur J Clin Microbiol Infect Dis; 1991 Jun; 10(6):519-24. PubMed ID: 1655433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant bactericidal/permeability-increasing protein (rBPI21) in combination with sulfadiazine is active against Toxoplasma gondii.
    Khan AA; Lambert LH; Remington JS; Araujo FG
    Antimicrob Agents Chemother; 1999 Apr; 43(4):758-62. PubMed ID: 10103177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rifabutin is active in murine models of toxoplasmosis.
    Araujo FG; Slifer T; Remington JS
    Antimicrob Agents Chemother; 1994 Mar; 38(3):570-5. PubMed ID: 8203856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minocycline in the chemotherapy of murine toxoplasmosis.
    Tabbara KF; Sakuragi S; O'Connor GR
    Parasitology; 1982 Apr; 84(Pt 2):297-302. PubMed ID: 7070843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxoplasma gondii: in vitro and in vivo activities of the hydroxynaphthoquinone 2-hydroxy-3-(1'-propen-3-phenyl)-1,4-naphthoquinone alone or combined with sulfadiazine.
    Ferreira RA; Oliveira AB; Ribeiro MF; Tafuri WL; Vitor RW
    Exp Parasitol; 2006 Jun; 113(2):125-9. PubMed ID: 16458300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azithromycin reduces ocular infection during congenital transmission of toxoplasmosis in the Calomys callosus model.
    Lopes CD; Silva NM; Ferro EA; Sousa RA; Firminot ML; Bernardes ES; Roque-Barreira MC; Pena JD
    J Parasitol; 2009 Aug; 95(4):1005-10. PubMed ID: 20050006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of sulfadiazine and pyrimetamine for treatment of experimental toxoplasmosis with strains obtained from human cases of congenital disease in Brazil.
    Silva LA; Fernandes MD; Machado AS; Reis-Cunha JL; Bartholomeu DC; Almeida Vitor RW
    Exp Parasitol; 2019 Jul; 202():7-14. PubMed ID: 31077733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five drug regimens for treatment of acute toxoplasmosis in squirrel monkeys.
    Harper JS; London WT; Sever JL
    Am J Trop Med Hyg; 1985 Jan; 34(1):50-7. PubMed ID: 3970309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of ketolides in combination with other drugs to treat experimental toxoplasmosis.
    Araujo FG; Khan AA; Bryskier A; Remington JS
    J Antimicrob Chemother; 1998 Nov; 42(5):665-7. PubMed ID: 9848454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro and in-vivo activities of roxithromycin in combination with pyrimethamine or sulphadiazine against Toxoplasma gondii.
    Romand S; Bryskier A; Moutot M; Derouin F
    J Antimicrob Chemother; 1995 Jun; 35(6):821-32. PubMed ID: 7559193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.